Star Imaging SME IPO GMP Today

GMP for Star Imaging SME started at Rs 0 on 5 August 2025 and stood at Rs 2 on 13 August 2025. The sharpest single-day jump was from Rs 0 on 11 Aug 2025 to Rs 3 on 12 Aug 2025. GMP has moved in both directions during the tracked period. That often means sentiment is unsettled and the final listing price is harder to predict.

Based on today's GMP, Star Imaging SME IPO listing price estimate is Rs 142.00 per share (issue price Rs 142.00 + GMP Rs 0.00).

Actual listing price will be known on 18 August 2025 when the stock lists on NSE/BSE.

Grey market activity is minimal or unavailable. GMP may appear once investor interest builds closer to the open date.

GMP is unofficial. Listing gain can differ on listing day.

GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Star Imaging SME is 5.67x. Compare this with the GMP trend to see if demand aligns. The GMP move around 12 Aug 2025 may reflect how the market reacted once the subscription window activity picked up after 8 Aug 2025.

See live figures on the Star Imaging SME IPO Subscription Status page.

Star Imaging SME IPO full details (financials, peers, review).

Star Imaging & Path Lab Ltd. is a healthcare service provider that offers comprehensive diagnostic imaging services and clinical laboratory tests, including both routine and specialized tests. The company's services span across various medical fields such as Radiology (X-ray, CT Scan, Mammography, 4D ultrasound, Bone Mineral Density), Pathology (Haematology, Microbiology, PCR, Histopathology, Immunology & Bio Chemistry), and Cardio-diagnostics. The company operates on a mixed business model, serving B2G (Public-private partnership model), B2C (direct consumers), and B2B (private hospitals) segments. In Fiscal 2024, B2G contributed 58.46% of the revenue, B2C 34.67%, and B2B 6.87%.